Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial

Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial

Bibliographic Details
Main Authors: Ji, Linong, Zinman, Bernard, Patel, Sanjay, Ji, Jinfeng, Bailes, Zelie, Thiemann, Sandra, Seck, Thomas
Format: Online
Language:English
Published: Springer Healthcare 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376958/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376958/

Similar Items